Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
703 Single cell analysis of phase II study of nivolumab and relatlimab in metastatic uveal melanoma reveals tumor and immune response to dual PD-1 and LAG-3 inhibition
Compose a Response to This Article
Other responses
No responses have been published for this article.
